March 19-21, 2024 | London, UK

As the industry consolidates pipelines and heads out of a turbulent 2023 market, the targeted protein degradation engine has shown no signs of slowing.

The 4th TPD Summit Europe returns as Europe’s definitive meeting for uniting Targeted Protein Degradation professionals within Europe and across the globe to explore novel degrader development with new E3 ligase/ligand discovery, overcome safety concerns in PROTACs, and rationally discover molecular glues to deliver clinically approved degraders to high-value targets and patients in need.

Across 3-days, Beacon’s Lead Research Analyst, Katie Spooner, will join the 35+ world-class TPD speaker faculty to uncover the bivalent degrader landscape, by taking a deep dive into the current bivalent degrader data available, including PROTACs, and looking into prospects of novel bivalent degrades. More information about Katie’s presentation during the Preclinical, Translational & Clinical Considerations Track can be found here or in the event guide available to download now.